Guhan Medicine: Announcement on the plan of the controlling shareholder acting in concert to increase its shareholding in the company
Securities code: 000590 Securities abbreviation: Guhan Medicine Announcement number: 2026-005
Guhan Pharmaceutical Group Co., Ltd.
Announcement on the plan of the controlling shareholder acting in concert to increase his shareholding in the company
The management consultants of the Shanghai Company and the Corporate Management Association of the Company guarantee that the company's information disclosed to the company is true, accurate, complete and true, and that there are no accurate, false, false records, misleading statements or major omissions.
Complete, without false records, misleading statements or material omissions.
The company and all members of the board of directors guarantee that the content of the announcement is consistent with the information provided by the information disclosure obligor. Special tips:
Shanghai Sailexian Enterprise Management Consulting Co., Ltd. (hereinafter referred to as "Shanghai Sailexian"), the concerted acting party of the controlling shareholder of Guhan Pharmaceutical Group Co., Ltd. (hereinafter referred to as the "Company"), based on its recognition of the company's long-term investment value and its confidence in sustained and stable development in the future, plans to increase its holdings of the company's shares within 6 months from the date of disclosure of this announcement. The total amount of the planned increase is not less than RMB 20 million.
This shareholding increase plan may involve the risk that the implementation of the shareholding increase plan may be delayed or cannot be completed due to changes in capital market conditions and other factors. Investors are advised to pay attention to investment risks.
Recently, the company received the "Notification Letter of Shanghai Sailexian Enterprise Management Consulting Co., Ltd.'s Plan to Increase its Shareholding in Guhan Pharmaceutical Group Co., Ltd." issued by Shanghai Sailexian. The relevant information is now announced as follows:
1. Basic information on the entities planning to increase holdings
Planned holding increase entity: Shanghai Sailexian Enterprise Management Consulting Co., Ltd. Shanghai Sailexian is the executive partner of Hunan Sailexian Management Consulting Services Partnership (Limited Partnership) (hereinafter referred to as "Hunan Sailexian"), the company's controlling shareholder. Before the implementation of this shareholding increase, Shanghai Sailexian held 1,100,000 shares of the company, accounting for 0.46% of the company's total share capital; Hunan Sailexian held 58,606,962 shares of the company, accounting for 24.47% of the company's total share capital. The above entities hold a total of 59,706,962 shares of the company, accounting for 24.93% of the company's total share capital.
Within 12 months before this announcement, Shanghai Sailexian did not disclose any plans to increase its shareholding in the company.
In the six months before this announcement, Shanghai Salexian did not reduce its shareholding in the company.
2. Main contents of the shareholding increase plan
The purpose of this increase in shareholding: based on the recognition of the company’s long-term investment value and confidence in its continued and stable development in the future.
The amount of the increased shareholding: not less than RMB 20 million.
The price of this increase in shares: Based on a reasonable judgment on the value of the company’s stock, Shanghai Sailexian will choose an opportunity to implement the increase plan during the increase period based on the company’s stock price fluctuations and the overall trend of the capital market. This increase plan will not set a price range.
The implementation period of this shareholding increase plan: no more than 6 months from the date of announcement, except for the period when laws, regulations, Shenzhen Stock Exchange business rules and other relevant regulations do not allow shareholding increase. During the implementation of the shareholding increase plan, if the company's stock is suspended from trading, the implementation period will be postponed.
The method of increasing shareholding this time: According to market conditions, it will be carried out through the methods allowed by the Shenzhen Stock Exchange (including but not limited to the centralized bidding trading system or the block trading system).
Source of funds for this increase in shareholding: own funds or self-raised funds.
This holding increase is not based on the specific identity of the holding owner. If the relevant identity is lost, the holding increase plan will continue to be implemented.
Commitments of the holding increase entity: Shanghai Sailexian promises not to reduce its shareholding in the company during the increase period and within the legal period, and will complete the increase plan within the above implementation period.
3. Uncertain risks in the implementation of the shareholding increase plan
This shareholding increase plan may involve the risk that the shareholding increase plan cannot be implemented or partially cannot be implemented due to changes in capital market conditions. Investors are advised to pay attention to investment risks.
4. Other related instructions
This shareholding increase plan complies with relevant laws and regulations such as the "Company Law of the People's Republic of China", "Administrative Measures for the Acquisition of Listed Companies", departmental regulations, normative documents, business rules of the Shenzhen Stock Exchange and other relevant provisions. 2. This shareholding increase will not cause the company's equity distribution to fail to meet listing conditions, nor will it cause a change in the company's control.
The company will continue to pay attention to the progress of this shareholding increase plan and perform its information disclosure obligations in a timely manner in accordance with relevant regulations.
5. Documents for reference
- "Notification letter of Shanghai Sailexian Enterprise Management Consulting Co., Ltd.'s plan to increase its shareholding in Guhan Pharmaceutical Group Co., Ltd."
Announcement is hereby made.
Board of Directors of Guhan Pharmaceutical Group Co., Ltd.
March 10, 2026